Tommaso Barba, a PhD candidate at Imperial College London’s Centre for Psychedelic Research, put a number on it this week that the field has been circling for years: 39%. In nearly 600 patients with treatment-resistant depression, episodes averaging more than three years in duration, 39% of those receiving a 25mg dose of psilocybin achieved a clinically meaningful […]